World News | Pfizer Tops Q1 Expectations, Revises 2022 Forecast
Get latest articles and stories on World at LatestLY. Sales of Pfizer's COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61per cent.
New York, May 3 (AP) Sales of Pfizer's COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61per cent.
The coronavirus vaccine Comirnaty brought in more than USD13 billion in sales, and the treatment Paxlovid added another USD1.5 billion as company revenue swelled 77per cent, the company said Tuesday.
Also Read | Twitter Bans 2 Right-Wing Accounts as Elon Musk Promotes Free Speech.
Pfizer posted adjusted earnings of USD1.62 per share in the first quarter, on USD25.66 billion in revenue.
Analysts expected per-share earnings of USD1.49 on about USD24.1 billion in sales, according to FactSet.
Also Read | Met Gala 2022: Hillary Clinton Turns Heads With Her Royal Entry at Met Gala Red Carpet After 21 Years.
Pfizer Inc., based in New York, also revised its 2022 earnings forecast to reflect an accounting policy change. It now expects adjusted earnings of USD6.25 to USD6.45 per share.
That's down from its previous forecast for USD6.35 to USD6.55 per share.
Analysts forecast earnings of USD7.14 per share.
Shares ticked slightly higher before the opening bell Thursday. (AP)
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)